Jneurosci: Highlights from the Dec. 14 issue

December 14, 2016

Check out these newsworthy studies from the Dec. 14, 2016, issue of JNeurosci. Media interested in obtaining the full text of the studies should contact media@sfn.org.

Working Memory Decline Linked to Loss of Specific Receptor in Rats

Working memory, the ability to hold a piece of information in mind for a short time, is essential to general cognitive ability and often deteriorates as we get older. Previous studies implicate receptors for the neurotransmitter glutamate in working memory function. In a new study in rats, researchers find glutamate receptors containing a specific protein subunit are required for working memory, with the loss of these receptors linked to working memory impairments. The results suggest therapies to precisely target these receptors may help improve working memory in older adults.

Corresponding author: Jennifer Bizon, bizonj@ufl.edu

Two-Way Communication Between Brain and Blood Vessels

An increase in brain activity triggers an increase in blood flow, ensuring a steady supply of oxygen and energy to the brain. In a new study using brain tissue from mice and rats, researchers find the communication between the brain and blood vessels is a two-way street during normal, resting conditions. Increases in blood pressure constrict blood vessels and diminish the baseline rate of neural firing, while decreases in blood pressure increase neural firing. The researchers propose this is a neuroprotective strategy, enabling neurons to adjust their baseline activity so they don't exhaust energy supplies.

Corresponding author: Jessica Filosa, jfilosa@augusta.edu

Receptor Targeted to Treat Insulin Resistance Also Involved in Stress Response

Pioglitazone, a drug used to treat type 2 diabetes, attenuates insulin resistance by binding to specific cellular receptors. Recent evidence indicates these receptors -- called peroxisome proliferator-activated receptor gamma, or PPAR-gamma -- may help regulate immune function in the central nervous system. In a new study, researchers find the receptors also play a role in the stress response: stimulating the receptors with pioglitazone reduced stress-induced anxiety in mice. The results suggest treatments stimulating PPAR-gamma may be beneficial for stress and anxiety disorders.

Corresponding author: Roberto Ciccocioppo, roberto.ciccocioppo@unicam.it
-end-
The Journal of Neuroscience is published by the Society for Neuroscience, an organization of nearly 38,000 basic scientists and clinicians who study the brain and nervous system.

Society for Neuroscience

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.